Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations

Pathology Research and Practice

Volumn 208, Issue 3, 2012, Pages 163-166

  Gurzu, Simona ^a   Jung, Ioan ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

BRAF mutation; Colorectal carcinomas; Cytokeratin 20; Cytokeratin 7; Microsatellite instability

Indexed keywords

B RAF KINASE; CYTOKERATIN 20; CYTOKERATIN 7; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KERATIN-20; KERATIN-7; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84858076248     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.01.003     Document Type: Article

References (17)

1. Bayrak R., Yenidunya S., Haltas H. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Pathol. Res. Pract. 2011, 207:156-160.
2. Chenevert J., Besette P., Plante M., et al. Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of literature. Pathol. Res. Pract. 2009, 205:657-661.
3. Hernandez B.Y., Frierson M.F., Moskaluk C.A., et al. CK20 and CK7 protein expression in colorectal carcinoma: demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 2005, 36:275-281.
4. Kidambi T., Mahajan A., DiBardino D. Cholangiocarcinoma presenting as metastases to the cervical spine. Am. J. Med. 2011, 124:e1-e2.
5. Matsumoto M., Nakajima T., Kato K., et al. Small invasive colon cancer with systemic metastasis: A case report. BMC Gastroenterol. 2011, 11:59.
6. McGregor D.K., Wu T.T., Rashid A., et al. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am. J. Surg. Pathol. 2004, 28:712-718.
7. O'Brien M.J., Yang S., Mack C., Xu H., Huang C.S., Mulcahy E., et al. Comparison of microsatellite instability, CpG island methylation phenotype BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma endpoints. Am. J. Surg. Pathol. 2006, 30:1491-1501.
8. Okido M., Seo M., Hamada Y., et al. Metastatic breast carcinoma simulating linitis plastica of the colon: report of a case. Surg. Today 2011, 41:542-545.
9. Radovic S., Selak I., Babic M., et al. Anti-cytokeratin 7: a positive marker for epithelial dysplasia in flat bowel mucosa. Bosn. J. Basci. Med. Sci. 2004, 4:24-30.
10. Righi A., Betts C.M., Marchetti C., et al. Merckel cells in the oral mucosa. Int. J. Surg. Pathol. 2006, 14:206-211.
11. Saad R.S., Silverman J.F., Khalifa M.A., et al. CDX2, cytokeratin 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl. Immunohistochem. Mol. Morphol. 2009, 17:196-201.
12. Sato K., Ueda Y., Kawamura K., et al. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study. Pathol. Res. Pract. 2009, 205:189-194.
13. Stefanius K., Ylitalo L., Tuomiosto A., Kuivila R., Kantola T., Sirniö P., et al. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology 2011, 58:679-692.
14. Stenling R., Lindberg J., Rutegard J., et al. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis. APMIS 2007, 115:1219-1226.
15. Tuppurainen K., Mäkinen J.M., Juntilla O., Liakka A., Kyllönen A.P., Tuominen H., et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J. Pathol. 2005, 207:285-294.
16. Zhang P.J., Shah M., Spiegel G.W., et al. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl. Immunohistochem. Mol. Morphol. 2003, 11:306-310.
17. Zhang X., Zheng P.S. Expression and significance of CK7 and CK19 in colon cancer. Xi. Bao. Yu. Fen. Zi. Mian. Yi. Xue. Za. Zhi. 2010, 26:157-158.